Case number 1:22-cv-01125
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 30, 2024 | 62 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,344,547. (Attachments: # 1 Stipulation of Dismissal)(ceg) (Entered: 05/30/2024) (0) |
| Jan 30, 2024 | 61 | NOTICE of Appearance by Andrew Mark Moshos on behalf of Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc., Mylan Pharmaceuticals Inc. (Moshos, Andrew) (Entered: 01/30/2024) (2) |
| Jan 30, 2024 | 60 | NOTICE of Appearance by Bindu Ann George Palapura on behalf of Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc., Mylan Pharmaceuticals Inc. (Palapura, Bindu) (Entered: 01/30/2024) (2) |
| Jan 30, 2024 | 59 | NOTICE of Appearance by David Ellis Moore on behalf of Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc., Mylan Pharmaceuticals Inc. (Moore, David) (Entered: 01/30/2024) (2) |
| Dec 27, 2023 | 58 | CONSENT to Jurisdiction by U.S. Magistrate Judge filed by H. Lundbeck A/S, Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Otsuka Pharmaceutical Co., Ltd., Viatris Inc. Case reassigned to Magistrate Judge Jennifer L. Hall. Signed by Judge Colm F. Connolly on 12/27/2023. (nmf) (Entered: 12/27/2023) (3) |
| Feb 21, 2023 | 55 | SO ORDERED, re (89 in 1:22-cv-00464-CFC, 45 in 1:22-cv-01226-CFC, 54 in 1:22-cv-01125-CFC, 46 in 1:22-cv-01367-CFC) STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to through and including March 10, 2023, filed by Viatris Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 2/21/2023. Associated Cases: 1:22-cv-00464-CFC, 1:22-cv-01125-CFC, 1:22-cv-01226-CFC, 1:22-cv-01367-CFC(kmd) (Entered: 02/21/2023) (2) |
| Feb 21, 2023 | 57 | SO ORDERED re (47 in 1:22-cv-01226-CFC, 56 in 1:22-cv-01125-CFC, 91 in 1:22-cv-00464-CFC, 48 in 1:22-cv-01367-CFC) STIPULATION AND ORDER REGARDING WITHDRAWAL OF VENUE MOTIONS, CONSOLIDATION OF ACTIONS AND SUBMISSION OF CASE SCHEDULE. CIVIL ACTION NO. 22-464-CFC SHALL BE THE LEAD CASE AND ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 22-464-CFC ONLY. ORDER LIFTING STAY. Order Setting Telephonic Scheduling Conference:( A Scheduling Conference is set for 3/8/2023 at 03:30 PM before Judge Colm F. Connolly. If the parties have no disputes regarding the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 2/21/2023. Associated Cases: 1:22-cv-00464-CFC, 1:22-cv-01125-CFC, 1:22-cv-01226-CFC, 1:22-cv-01367-CFC(nmf) (Entered: 02/21/2023) (5) |
| Feb 21, 2023 | 56 | STIPULATION and Proposed Order Regarding Withdrawal of Venue Motions, Consolidation of Actions and Submission of Case Schedule re (32 in 1:22-cv-01125-CFC, 67 in 1:22-cv-00464-CFC, 23 in 1:22-cv-01226-CFC, 24 in 1:22-cv-01367-CFC) Order Staying Case, (51 in 1:22-cv-01125-CFC, 42 in 1:22-cv-01226-CFC, 86 in 1:22-cv-00464-CFC, 43 in 1:22-cv-01367-CFC) Letter,, (42 in 1:22-cv-01367-CFC, 85 in 1:22-cv-00464-CFC, 50 in 1:22-cv-01125-CFC) Notice (Other),,, (41 in 1:22-cv-01226-CFC) Notice (Other),, by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc., Mylan Pharmaceuticals Inc.. (Haynes, Christine) (Entered: 02/21/2023) (5) |
| Feb 17, 2023 | 54 | STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to through and including March 10, 2023 - filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc., Mylan Pharmaceuticals Inc.. (Haynes, Christine) (Entered: 02/17/2023) (2) |
| Feb 6, 2023 | 53 | SO ORDERED, re (52 in 1:22-cv-01125-CFC, 87 in 1:22-cv-00464-CFC, 43 in 1:22-cv-01226-CFC, 44 in 1:22-cv-01367-CFC) STIPULATION TO EXTEND TIME for parties to submit a proposed protective order to February 17, 2023, filed by Viatris Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 2/6/2023. Associated Cases: 1:22-cv-00464-CFC, 1:22-cv-01125-CFC, 1:22-cv-01226-CFC, 1:22-cv-01367-CFC(kmd) (Entered: 02/06/2023) (2) |
| Feb 3, 2023 | 52 | STIPULATION TO EXTEND TIME for parties to submit a proposed protective order to February 17, 2023 - filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc., Mylan Pharmaceuticals Inc.. (Haynes, Christine) (Entered: 02/03/2023) (2) |
| Feb 1, 2023 | 51 | Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding Notice of Withdrawal withdrawing MPI and Viatris pending motions to dismiss for improper venue, failure to state a claim, and lack of subject matter jurisdiction - re (13 in 1:22-cv-01367-CFC) MOTION to Dismiss for Failure to State a Claim , (42 in 1:22-cv-01367-CFC, 85 in 1:22-cv-00464-CFC, 50 in 1:22-cv-01125-CFC) Notice (Other),,, (41 in 1:22-cv-01226-CFC) Notice (Other),, (12 in 1:22-cv-01226-CFC) MOTION to Dismiss for Failure to State a Claim , (12 in 1:22-cv-01125-CFC) MOTION to Dismiss for Improper Venue , (17 in 1:22-cv-00464-CFC) MOTION to Dismiss for Improper Venue . (Cottrell, Frederick) (Entered: 02/01/2023) (2) |
| Feb 1, 2023 | 50 | NOTICE of withdraw Defendants MPI and Viatris motions to dismiss for improper venue, failure to state a claim, and lack of subject matter jurisdiction (Case No. 22-464, D.I. 17; Case No. 22-1125, D.I. 12; Case No. 22-1226, D.I. 12; Case No. 22-1367, D.I. 13). Defendant MLL withdraws its motion to transfer (Case No. 22-464, D.I. 49) by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc., Mylan Pharmaceuticals Inc. re (13 in 1:22-cv-01367-CFC) MOTION to Dismiss for Failure to State a Claim , (49 in 1:22-cv-00464-CFC) MOTION to Transfer or Dismiss , (12 in 1:22-cv-01125-CFC) MOTION to Dismiss for Improper Venue , (17 in 1:22-cv-00464-CFC) MOTION to Dismiss for Improper Venue (Cottrell, Frederick) (Entered: 02/01/2023) (2) |
| Jan 27, 2023 | 49 | SO ORDERED, re (40 in 1:22-cv-01367-CFC, 39 in 1:22-cv-01226-CFC, 48 in 1:22-cv-01125-CFC, 83 in 1:22-cv-00464-CFC) STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to February 3, 2023, filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 1/27/2023. Associated Cases: 1:22-cv-00464-CFC, 1:22-cv-01125-CFC, 1:22-cv-01226-CFC, 1:22-cv-01367-CFC(kmd) (Entered: 01/27/2023) (2) |
| Jan 26, 2023 | 48 | STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to February 3, 2023 - filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc.. (Haynes, Christine) (Entered: 01/26/2023) (2) |
| Jan 20, 2023 | 47 | SO ORDERED, re (46 in 1:22-cv-01125-CFC, 81 in 1:22-cv-00464-CFC, 38 in 1:22-cv-01367-CFC, 37 in 1:22-cv-01226-CFC) STIPULATION TO EXTEND TIME for parties to submit a proposed protective order to January 27, 2023, filed by Viatris Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 1/20/2023. Associated Cases: 1:22-cv-00464-CFC, 1:22-cv-01125-CFC, 1:22-cv-01226-CFC, 1:22-cv-01367-CFC(kmd) (Entered: 01/20/2023) (2) |
| Jan 19, 2023 | 46 | STIPULATION TO EXTEND TIME for parties to submit a proposed protective order to January 27, 2023 - filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc., Mylan Pharmaceuticals Inc.. (Haynes, Christine) (Entered: 01/19/2023) (2) |
| Jan 13, 2023 | 45 | SO ORDERED, re (79 in 1:22-cv-00464-CFC, 35 in 1:22-cv-01226-CFC, 44 in 1:22-cv-01125-CFC, 36 in 1:22-cv-01367-CFC) Stipulation Seeking to Extend the Deadline by which a Proposed Protective Order is Due, filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. The deadline by which the parties must submit a proposed protective order in each of the four actions is extended through and including January 20, 2023. Signed by Judge Colm F. Connolly on 1/13/2023. Associated Cases: 1:22-cv-00464-CFC, 1:22-cv-01125-CFC, 1:22-cv-01226-CFC, 1:22-cv-01367-CFC(kmd) (Entered: 01/13/2023) (2) |
| Jan 13, 2023 | 44 | STIPULATION Seeking to Extend the Deadline by which a Proposed Protective Order is Due, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 01/13/2023) (2) |
| Jan 6, 2023 | 43 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission (Nos. 1-5) to Defendants Viatris, MLL and MPI filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew) (Entered: 01/06/2023) (2) |
| Jan 6, 2023 | 42 | NOTICE to Take Deposition of Jerry Toppins on a time and place to be agreed upon by the parties - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew) (Entered: 01/06/2023) (2) |
| Jan 6, 2023 | 41 | NOTICE OF SERVICE of Notice of Deposition of Defendant Mylan Laboratories Limited Pursuant to Rule 30(b)(6), Notice of Deposition of Defendant Mylan Pharmaceuticals Inc. Pursuant to Rule 30(b)(6), and Notice of Deposition of Defendant Viatris Inc. Pursuant to Rule 30(b)(6) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew) (Entered: 01/06/2023) (2) |
| Jan 6, 2023 | 40 | NOTICE to Take Deposition of Wayne Talton on a time and place to be agreed upon by the parties - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew) (Entered: 01/06/2023) (2) |
| Jan 6, 2023 | 39 | NOTICE OF SERVICE of First Set of Interrogatories filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc..(Haynes, Christine) (Entered: 01/06/2023) (2) |
| Jan 6, 2023 | 38 | NOTICE to Take Deposition of Satyanarayana Jujjavarapu on a time and place to be agreed upon by the parties - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew) (Entered: 01/06/2023) (2) |
| Jan 6, 2023 | 37 | NOTICE to Take Deposition of Michael Plastina on a time and place to be agreed upon by the parties - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew) (Entered: 01/06/2023) (2) |
| Jan 6, 2023 | 36 | NOTICE to Take Deposition of Keith Meckstroth on a time and place to be agreed upon by the parties - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew) (Entered: 01/06/2023) (2) |
| Jan 6, 2023 | 35 | NOTICE to Take Deposition of Jude Christopher Gorski on a time and place to be agreed upon by the parties - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew) (Entered: 01/06/2023) (2) |
| Jan 6, 2023 | 34 | NOTICE to Take Deposition of Amy L. Martin on a time and place to be agreed upon by the parties - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew) (Entered: 01/06/2023) (2) |
| Jan 6, 2023 | 33 | NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories (Nos. 1-24) to Defendants Viatris, MLL and MPI and Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-73) to Defendants Viatris, MLL and MPI filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew) (Entered: 01/06/2023) (2) |
| Dec 16, 2022 | 32 | ORDER REGARDING DISCOVERY AND STAY OF ALL OTHER PROCEEDINGS. (SEE ORDER FOR FURTHER DETAILS.) Signed by Judge Colm F. Connolly on 12/16/2022. Associated Cases: 1:22-cv-00464-CFC, 1:22-cv-01125-CFC, 1:22-cv-01226-CFC, 1:22-cv-01367-CFC(nmf) (Entered: 12/16/2022) (4) |
| Dec 15, 2022 | 31 | Letter to The Honorable Colm F. Connolly from Andrew C. Mayo regarding proposed order for discovery and stay of other proceedings. (Attachments: # 1 Text of Proposed Order)(Mayo, Andrew) (Entered: 12/15/2022) (Text of Proposed Order) (4) |
| Dec 15, 2022 | 31 | Letter to The Honorable Colm F. Connolly from Andrew C. Mayo regarding proposed order for discovery and stay of other proceedings. (Attachments: # 1 Text of Proposed Order)(Mayo, Andrew) (Entered: 12/15/2022) (Main Document) (2) |
| Dec 9, 2022 | 30 | Joint STIPULATION TO EXTEND TIME to Submit a Form of Proposed Order to December 15, 2022 - filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc.. (Haynes, Christine) (Entered: 12/09/2022) (2) |
| Dec 1, 2022 | N/A | SO ORDERED, re (21 in 1:22-cv-01367-CFC, 29 in 1:22-cv-01125-CFC, 20 in 1:22-cv-01226-CFC) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Paul W. Browning, Denise Main, Jennifer H. Roscetti, Erin M. Sommers, Jeanette M. Roorda, and Melanie Magdun, filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Ordered by Judge Colm F. Connolly on 12/1/2022. Associated Cases: 1:22-cv-01125-CFC, 1:22-cv-01226-CFC, 1:22-cv-01367-CFC(kmd) (Entered: 12/01/2022) (0) |
| Nov 30, 2022 | N/A | SO ORDERED, re (28 in 1:22-cv-01125-CFC) (20 in 1:22-cv-01367-CFC) (19 in 1:22-cv-01226-CFC) MOTION for Pro Hac Vice Appearance of Attorney Brandon M. White, Shannon M. Bloodworth, Emily J. Greb, Maria A. Stubbings, and Jonathan I. Tietz, filed by Viatris Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. Ordered by Judge Colm F. Connolly on 11/30/2022. Associated Cases: 1:22-cv-01125-CFC, 1:22-cv-01226-CFC, 1:22-cv-01367-CFC(kmd) (Entered: 11/30/2022) (0) |
| Nov 30, 2022 | 29 | MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Paul W. Browning, Denise Main, Jennifer H. Roscetti, Erin M. Sommers, Jeanette M. Roorda, and Melanie Magdun - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew) (Entered: 11/30/2022) (11) |
| Nov 29, 2022 | 28 | MOTION for Pro Hac Vice Appearance of Attorney Brandon M. White, Shannon M. Bloodworth, Emily J. Greb, Maria A. Stubbings, and Jonathan I. Tietz - filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc.. (Haynes, Christine) (Entered: 11/29/2022) (7) |
| Nov 29, 2022 | 27 | NOTICE of Appearance by Jason James Rawnsley on behalf of Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc. (Rawnsley, Jason) (Entered: 11/29/2022) (1) |
| Nov 1, 2022 | 26 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Viatris Inc.. (Cottrell, Frederick) (Entered: 11/01/2022) (2) |
| Oct 25, 2022 | 25 | REQUEST for Oral Argument by Mylan Pharmaceuticals Inc., Viatris Inc. re 12 MOTION to Dismiss for Improper Venue . (Cottrell, Frederick) (Entered: 10/25/2022) (2) |
| Oct 25, 2022 | 24 | REQUEST for Oral Argument by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd. re 12 MOTION to Dismiss for Improper Venue . (Balick, Steven) (Entered: 10/25/2022) (2) |
| Oct 24, 2022 | 23 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc., Other Affiliate Viatris Inc. for Mylan Pharmaceuticals Inc. filed by Mylan Pharmaceuticals Inc.. (Cottrell, Frederick) (Entered: 10/24/2022) (2) |
| Oct 24, 2022 | 22 | REDACTED VERSION of 19 Reply Brief re Motion to Dismiss by Mylan Pharmaceuticals Inc., Viatris Inc.. (Haynes, Christine) (Entered: 10/24/2022) (6) |
| Oct 18, 2022 | 21 | REDACTED VERSION of 17 Declaration of Jeanette M. Roorda by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 10/18/2022) (30) |
| Oct 18, 2022 | 20 | REDACTED VERSION of 16 Answering Brief in Opposition by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 10/18/2022) (5) |
| Oct 18, 2022 | 19 | [SEALED] Supplemental REPLY BRIEF re 12 MOTION to Dismiss for Improper Venue filed by Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # 1 Certificate of Compliance)(Cottrell, Frederick) (Entered: 10/18/2022) (0) |
| Oct 12, 2022 | 18 | NOTICE of Absence of Consent to Proceed Before A United States Magistrate Judge, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd. (Balick, Steven) (Entered: 10/12/2022) (1) |
| Oct 11, 2022 | 17 | [SEALED] DECLARATION re 16 Answering Brief in Opposition (Declaration of Jeanette M. Roorda) by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit A-I)(Balick, Steven) (Entered: 10/11/2022) (0) |
| Oct 11, 2022 | 16 | [SEALED] ANSWERING BRIEF in Opposition re 12 MOTION to Dismiss for Improper Venue filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..Reply Brief due date per Local Rules is 10/18/2022. (Balick, Steven) (Entered: 10/11/2022) (0) |
| Sep 28, 2022 | 15 | ORAL ORDER: It is HEREBY ORDERED that on or before October 12, 2022, the parties shall, after meeting and conferring, complete and file the "Notice of Consent or Absence of Consent to Proceed Before A United States Magistrate Judge" that has been docketed with this Order. Ordered by Judge Colm F. Connolly on 9/28/2022. (nmf) (Entered: 09/28/2022) (1) |
| Sep 27, 2022 | 14 | SO ORDERED, re 11 Stipulation Regarding Mylan Pharmaceutical Inc.'s and Viatris Inc.'s Response to the Complaint, filed by Viatris Inc., Mylan Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 9/27/2022. (kmd) (Entered: 09/27/2022) (4) |
| Sep 26, 2022 | 12 | MOTION to Dismiss for Improper Venue - filed by Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # 1 Text of Proposed Order)(Cottrell, Frederick) (Entered: 09/26/2022) (Text of Proposed Order) (2) |
| Sep 26, 2022 | 13 | Supplemental OPENING BRIEF in Support re 12 MOTION to Dismiss for Improper Venue filed by Mylan Pharmaceuticals Inc., Viatris Inc..Answering Brief/Response due date per Local Rules is 10/11/2022. (Attachments: # 1 Certificate of Compliance)(Cottrell, Frederick) (Entered: 09/26/2022) (Certificate of Compliance) (1) |
| Sep 26, 2022 | 13 | Supplemental OPENING BRIEF in Support re 12 MOTION to Dismiss for Improper Venue filed by Mylan Pharmaceuticals Inc., Viatris Inc..Answering Brief/Response due date per Local Rules is 10/11/2022. (Attachments: # 1 Certificate of Compliance)(Cottrell, Frederick) (Entered: 09/26/2022) (Main Document) (4) |
| Sep 26, 2022 | 12 | MOTION to Dismiss for Improper Venue - filed by Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # 1 Text of Proposed Order)(Cottrell, Frederick) (Entered: 09/26/2022) (Main Document) (2) |
| Sep 26, 2022 | 11 | STIPULATION Regarding Mylan Pharmaceutical Inc.'s and Viatris Inc.'s Response to the Complaint by Mylan Pharmaceuticals Inc., Viatris Inc.. (Haynes, Christine) (Entered: 09/26/2022) (4) |
| Sep 20, 2022 | N/A | SO ORDERED, re 9 STIPULATION TO EXTEND TIME to respond to the Complaint to September 26, 2022, filed by Viatris Inc., Mylan Pharmaceuticals Inc. Reset Answer Deadlines: Mylan Pharmaceuticals Inc. answer due 9/26/2022; Viatris Inc. answer due 9/26/2022. Ordered by Judge Colm F. Connolly on 9/20/2022. (kmd) (Entered: 09/20/2022) (0) |
| Sep 19, 2022 | 10 | NOTICE of Appearance by Frederick L. Cottrell, III on behalf of Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc. (Cottrell, Frederick) (Entered: 09/19/2022) (1) |
| Sep 16, 2022 | 9 | STIPULATION TO EXTEND TIME to respond to the Complaint to September 26, 2022 - filed by Mylan Pharmaceuticals Inc., Viatris Inc.. (Haynes, Christine) (Entered: 09/16/2022) (2) |
| Aug 31, 2022 | N/A | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) (Entered: 08/31/2022) (0) |
| Aug 29, 2022 | 7 | SUMMONS Returned Executed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Mylan Pharmaceuticals Inc. served on 8/29/2022, answer due 9/19/2022. (Balick, Steven) (Entered: 08/29/2022) (2) |
| Aug 29, 2022 | 8 | SUMMONS Returned Executed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Viatris Inc. served on 8/29/2022, answer due 9/19/2022. (Balick, Steven) (Entered: 08/29/2022) (2) |
| Aug 26, 2022 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc. ( Filing fee $ 402, receipt number ADEDC-3946348.) - filed by Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet) (mkr) (Entered: 08/29/2022) (Main Document) (23) |
| Aug 26, 2022 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc. ( Filing fee $ 402, receipt number ADEDC-3946348.) - filed by Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet) (mkr) (Entered: 08/29/2022) (Exhibit A) (11) |
| Aug 26, 2022 | N/A | No Summons Issued. (mkr) (Entered: 08/29/2022) (0) |
| Aug 26, 2022 | 6 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S.(mkr) (Entered: 08/29/2022) (1) |
| Aug 26, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd.(mkr) (Entered: 08/29/2022) (1) |
| Aug 26, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number 11,344,547.(mkr) (Entered: 08/29/2022) (1) |
| Aug 26, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/27/2022. Date of Expiration of Patent: 9/24/2033.Thirty Month Stay Deadline: 8/24/2024. (mkr) (Entered: 08/29/2022) (2) |
| Aug 26, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 08/29/2022) (3) |
| Aug 26, 2022 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc. ( Filing fee $ 402, receipt number ADEDC-3946348.) - filed by Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet) (mkr) (Entered: 08/29/2022) (Civil Cover Sheet) (2) |
